Serum leptin levels during recombinant human GH therapy in adults with GH deficiency

European Journal of Endocrinology

Volumn 137, Issue 6, 1997, Pages 650-654

  Janssen, Y J H ^a   Frolich M ^a   Deurenberg, P ^b   Roelfsema, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEUTERIUM; DEUTERIUM OXIDE; GROWTH HORMONE; HUMAN GROWTH HORMONE; LEPTIN; SOMATOMEDIN C; WATER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY FAT; BODY WATER; CLINICAL ARTICLE; FEMALE; GENE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; BODY COMPOSITION; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MIDDLE AGED; PROTEINS; RECOMBINANT PROTEINS;

EID: 2642665533     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370650     Document Type: Article

References (32)

1. Campfield LA, Smith FJ, Guisez Y, Devos R & Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995 269 546-549.
2. Stephens TW, Basinsky M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995 377 530-532.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 543-546.
4. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. Journal of Clinical Investigation 1995 96 2065-2070.
5. Binnerts A, Deurenberg P, Swart GR, Wilson JH & Lamberts SW. Body composition in growth hormone-deficient adults. American Journal of Clinical Nutrition 1992 55 918-923.
6. Rosén T, Bosaeus I, Tolli J, Lindstedt G & Bengtsson BÅ. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clinical Endocrinology 1993 38 63-71.
7. Jørgensen JO, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 1 1221-1225.
8. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803.
9. Bengtsson BÅ, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1995 76 309-317.
10. Deurenberg P, Tagliabue A & Schouten FJ. Multi-frequency impedance for the prediction of extracellular water and total body water. British Journal of Nutrition 1995 73 349-358.
11. Pace N & Rathbun EN. Studies on body composition: water and chemically combined nitrogen content in relation to fat content. Journal of Biological Chemistry 1945 158 685-691.
12. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH & Landt M. Radioimmunoassay of leptin in human plasma. Clinical Chemistry 1996 42 942-946.
13. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM et al. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy. Acta Endocrinologica 1993 128 (Suppl 2) 44-47.
14. Harant I, Beauville M, Crampes F, Riviere D, Tauber MT, Tauber JP et al. Response of fat cells to growth hormone (GH): effect of long term treatment with recombinant human GH in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1994 78 1392-1395.
15. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. Journal of Clinical Endocrinology and Metabolism 1996 81 3424-3427.
16. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 1996 334 292-295.
17. Ostlund RE, Jr, Yang JW, Klein S & Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. Journal of Clinical Endocrinology and Metabolism 1996 81 3909-3913.
18. Salbe AD, Nicolson M & Ravussin E. Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. Journal of Clinical Investigation 1997 99 592-595.
19. Janssen YJH, Deurenberg P & Roelfsema F. Using dilution techniques and multi-frequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during rhGH treatment in GH deficient adults. Journal of Clinical Endocrinology and Metabolism 1997 82 3349-3355.
20. Florkowski CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA & Donald RA. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clinical Endocrinology 1996 45 769-773.
21. Brabant G, Horn R, Mayr B, von zur Muhlen A, Honegger J & Buchfelder M. Serum leptin levels following hypothalamic surgery. Hormone and Metabolic Research 1996 28 728-731.
22. Wing RR, Sinha MK, Considine RV, Lang W & Caro JF. Relationship between weight loss maintenance and changes in serum leptin levels. Hormone and Metabolic Research 1996 28 698-703.
23. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR & Kuijper JL. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. Journal of Clinical Endocrinology and Metabolism 1997 82 561-565.
24. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL & Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. Journal of Clinical Endocrinology and Metabolism 1996 81 4406-4413.
25. Pratley RE, Nicolson M, Bogardus C & Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. Journal of Clinical Endocrinology and Metabolism 1996 81 4418-4421.
26. Clapham JC, Smith SA, Moore GB, Hughes MG, Azam H, Scott A et al. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. International Journal of Obesity and Related Metabolic Disorders 1997 21 179-183.
27. Kohrt WM, Landt M & Birge SJ. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. Journal of Clinical Endocrinology and Metabolism 1996 81 3980-3985.
28. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J & Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996 45 695-698.
29. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R et al. Sexual dimorphism in plasma leptin concentration. Journal of Clinical Endocrinology and Metabolism 1997 82 579-584.
30. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R et al. Acute and chronic effect of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996 45 699-701.
31. Johansson JO, Fowelin J, Landin K, Lager I & Bengtsson BÅ. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995 44 1126-1129.
32. Fowelin J, Attvall S, Lager I & Bengtsson BÅ. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993 42 1443-1447.